Josh Tarnoff

Josh Tarnoff

Company: NephCure Kidney International

Job title: Chief Executive Officer

Bio:

Josh Tarnoff is the Chief Executive Officer for NephCure. He came to NephCure in early 2018 when he fulfilled a long-held desire to more closely serve the rare disease patient community. Josh spent over 30 years working in the pharmaceutical and biotechnology community moving new therapies closer to reality. Personal contact with NephCure families drives his passion to achieve the goals of our mission and he always appreciates directly speaking with our community. Likely due to a snake bite, he also has personal insights into renal disease having been a patient. Josh lives in PA where he enjoys backpacking while also trying to avoid further contact with venomous snakes.

Seminars:

Panel Discussion: Supporting Enrolment of Minority Patients 12:00 pm

Read more

day: Track 2 - Day 2

FSGS: Finding the Patients 11:30 am

Read more

day: Track 2 - Day 2

Panel Discussion: Advantages & Disadvantages of Targeting Trials to Specific Orphan Indications Versus Larger Public Health Problems 1:45 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.